全文获取类型
收费全文 | 1139912篇 |
免费 | 74588篇 |
国内免费 | 1772篇 |
专业分类
耳鼻咽喉 | 14819篇 |
儿科学 | 37494篇 |
妇产科学 | 28780篇 |
基础医学 | 181797篇 |
口腔科学 | 30533篇 |
临床医学 | 102593篇 |
内科学 | 215158篇 |
皮肤病学 | 25749篇 |
神经病学 | 79477篇 |
特种医学 | 42262篇 |
外国民族医学 | 126篇 |
外科学 | 169693篇 |
综合类 | 21695篇 |
现状与发展 | 3篇 |
一般理论 | 252篇 |
预防医学 | 83317篇 |
眼科学 | 26417篇 |
药学 | 87012篇 |
4篇 | |
中国医学 | 3269篇 |
肿瘤学 | 65822篇 |
出版年
2021年 | 8675篇 |
2018年 | 12592篇 |
2017年 | 9499篇 |
2016年 | 10760篇 |
2015年 | 12008篇 |
2014年 | 16247篇 |
2013年 | 24365篇 |
2012年 | 33620篇 |
2011年 | 36067篇 |
2010年 | 21092篇 |
2009年 | 19504篇 |
2008年 | 33261篇 |
2007年 | 36076篇 |
2006年 | 35969篇 |
2005年 | 34002篇 |
2004年 | 33158篇 |
2003年 | 31762篇 |
2002年 | 30782篇 |
2001年 | 54943篇 |
2000年 | 55825篇 |
1999年 | 46167篇 |
1998年 | 12264篇 |
1997年 | 10376篇 |
1996年 | 10664篇 |
1995年 | 10040篇 |
1994年 | 9180篇 |
1992年 | 34750篇 |
1991年 | 35359篇 |
1990年 | 34693篇 |
1989年 | 34329篇 |
1988年 | 31294篇 |
1987年 | 30669篇 |
1986年 | 28906篇 |
1985年 | 27374篇 |
1984年 | 20218篇 |
1983年 | 17183篇 |
1982年 | 9371篇 |
1979年 | 18809篇 |
1978年 | 13256篇 |
1977年 | 10946篇 |
1976年 | 10946篇 |
1975年 | 12543篇 |
1974年 | 14485篇 |
1973年 | 13942篇 |
1972年 | 13009篇 |
1971年 | 12308篇 |
1970年 | 11767篇 |
1969年 | 10881篇 |
1968年 | 10125篇 |
1967年 | 9025篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
51.
52.
53.
A case of bullous pemphigoid associated with psoriasis vulgaris showing Hailey–Hailey disease‐like histopathological changes in regenerated epidermis without genomic mutation in ATP2C1 or ATP2A2 gene 下载免费PDF全文
54.
C. Dessinioti C.C. Zouboulis V. Bettoli D. Rigopoulos 《Journal of the European Academy of Dermatology and Venereology》2020,34(10):2229-2240
Guidelines and consensus on the management of patients with acne aim to give evidence-based, expert-group recommendations. This review compares current guidelines and consensus articles to provide a compilation of recommendations on the treatment of acne with oral isotretinoin. Ten common, relevant, clinical questions are addressed, based on published recommendations, including the indications of isotretinoin, the proposed daily dose, the cumulative isotretinoin dose and the laboratory monitoring needed. Recommendations on special considerations are also addressed, including the timing of procedures and the question of an association of depression or inflammatory bowel disease with isotretinoin. A major limitation is the use of different classification systems for acne across guidelines. The recommended daily dose ranges from 0.3 to 0.5 mg/kg in the European guidelines to up to 1 mg/kg in the US guidelines. A specific duration of treatment of at least 6 months is only recommended in the European guidelines. All guidelines report the need of strict pregnancy prevention measures. The European, French and US guidelines recommend to monitor for symptoms of depression. Important clinical questions that are inconsistently addressed in guidelines include the age indication, the recommendation for a cumulative dose, the timing of procedures, the association of isotretinoin with IBD, the recommendation for preventing acne flares and for appropriate laboratory monitoring. These topics should be clearly included in the recommendations of guidelines as they are often raised in everyday clinical practice. 相似文献
55.
56.
Context Withania somnifera (L.) Dunal is traditionally used for treating various ailments, but lacks scientific evaluation.Objective This study evaluates Withania somnifera (WS) for its effect on platelet activity and inflammatory enzymes.Materials and methods Aqueous and ethanolic (1:1) leaf extracts were subjected to in vitro indirect haemolytic activity using Naja naja venom, human platelet aggregation was quantified for lipid peroxidation using arachidonic acid (AA) as agonist and 5-lipoxygenase (5-LOX) levels were determined using standard spectrometric assays. Further, molecular docking was performed by the ligand fit method using molegro software package (Molegro ApS, Aarhus, Denmark).Results The study found that aqueous and ethanol extracts have very negligible effect (15%) with an IC50 value of 13.8?mg/mL on PLA2 from Naja naja venom. Further, extracts of WS also had very little effect (18%) with an IC50 value of 16.6?mg/mL on malondialdehyde (MDA) formation. However, a 65% inhibition of 5-LOX with an IC50 value of 0.92?mg/mL was observed in 1:1 ethanol extracts. The same was evident from SAR model with the active ingredient withaferin A binding predominantly on Phe 77, Tyr 98, Arg 99, Asp 164, Leu 168, Ser 382, Arg 395, Tyr 396 and Tyr 614 with an atomic contact energy value of??128.96 compared to standard phenidone (?103.61). Thus, the current study validates the application of WS for inflammatory diseases.Conclusion This study reveals the inhibitory potential of W. somnifera on inflammatory enzymes and platelet aggregation. Thus, WS can serve as a newer, safer and affordable medicine for inflammatory diseases. 相似文献
57.
Feasibility and Diagnostic Potential of Pulmonary Transit Time Measurement by Contrast Echocardiography: A Pilot Study 下载免费PDF全文
58.
Weiyu Ye Anna Olsson-Brown Robert A. Watson Vincent T. F. Cheung Robert D. Morgan Isar Nassiri Rosalin Cooper Chelsea A. Taylor Umair Akbani Oliver Brain Rubeta N. Matin Nicholas Coupe Mark R. Middleton Mark Coles Joseph J. Sacco Miranda J. Payne Benjamin P. Fairfax 《British journal of cancer》2021,124(10):1661
Background Immune checkpoint blockers (ICBs) activate CD8+ T cells, eliciting both anti-cancer activity and immune-related adverse events (irAEs). The relationship of irAEs with baseline parameters and clinical outcome is unclear.Methods Retrospective evaluation of irAEs on survival was performed across primary (N = 144) and secondary (N = 211) independent cohorts of patients with metastatic melanoma receiving single agent (pembrolizumab/nivolumab—sICB) or combination (nivolumab and ipilimumab—cICB) checkpoint blockade. RNA from pre-treatment and post-treatment CD8+ T cells was sequenced and differential gene expression according to irAE development assessed.Results 58.3% of patients developed early irAEs and this was associated with longer progression-free (PFS) and overall survival (OS) across both cohorts (log-rank test, OS: P < 0.0001). Median survival for patients without irAEs was 16.6 months (95% CI: 10.9–33.4) versus not-reached (P = 2.8 × 10−6). Pre-treatment monocyte and neutrophil counts, but not BMI, were additional predictors of clinical outcome. Differential expression of numerous gene pathway members was observed in CD8+ T cells according to irAE development, and patients not developing irAEs demonstrating upregulated CXCR1 pre- and post-treatment.Conclusions Early irAE development post-ICB is associated with favourable survival in MM. Development of irAEs is coupled to expression of numerous gene pathways, suggesting irAE development in-part reflects baseline immune activation.Subject terms: Immunotherapy, Melanoma 相似文献
59.